Regulatory guidelines and existing protocols to govern aspects of mRNA quality during development and manufacturing are still evolving, creating a lack of clarity and consensus amongst the mRNA community.

Without a clear path forward, drug developers risk comprising product quality, safety and efficacy, and so the 2nd mRNA Quality Control & Compliance Summit is back to Boston this June as the sole industry-centred forum dedicated to showcasing data and discussions on mRNA compliance and optimized documentation, ensuring streamlined approval for mRNA therapeutics and vaccines!

Reuniting industry experts in quality control, quality assurance, analytical development, and CMC, this forum aims to navigate regulatory guidelines and identify tangible best practices towards optimized documentation, discuss verification processes for platform methods and review method validation used to evaluate critical vaccine qualities, all towards safeguarding faster mRNA drug approvals in line with regulatory expectations.

Download the free brochure or book your place now, early birds are still available!